Yahoo Finance • 23 days ago
MALVERN, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neuroh... Full story
Yahoo Finance • 2 months ago
MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who su... Full story
Yahoo Finance • 2 months ago
Investing.com - Canaccord Genuity lowered its price target on Neuronetics (NASDAQ:STIM) to $7.00 from $8.00 on Wednesday, while maintaining a Buy rating on the stock. The medical device company, with a market capitalization of $300 milli... Full story
Yahoo Finance • 2 months ago
Earnings Call Insights: Neuronetics (STIM) Q2 2025 MANAGEMENT VIEW * CEO Keith Sullivan highlighted a strong second quarter, stating, “We had a strong second quarter at Neuronetics, both in terms of our ability to drive accelerated top... Full story
Yahoo Finance • 2 months ago
Neuronetics Inc (NASDAQ:STIM [https://www.chartmill.com/stock/quote/STIM/profile]) reported its second-quarter 2025 financial results, delivering mixed performance relative to analyst expectations. While revenue exceeded estimates, the com... Full story
Yahoo Finance • 2 months ago
* Neuronetics press release [https://seekingalpha.com/pr/20188747-neuronetics-reports-second-quarter-2025-financial-and-operating-results] (NASDAQ:STIM [https://seekingalpha.com/symbol/STIM]): Q2 GAAP EPS of -$0.15 misses by $0.07. * R... Full story
Yahoo Finance • 2 months ago
Delivered $38.1 million total revenue in the quarter, representing 18% adjusted pro forma revenue growth Generated record Greenbrook clinic revenue of $23.0 million in the quarter Reduced cash used in operations to $3.5 million, beating... Full story
Yahoo Finance • 2 months ago
MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever... Full story
Yahoo Finance • 2 months ago
MALVERN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story
Yahoo Finance • 3 months ago
MALVERN, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story
Yahoo Finance • 3 months ago
Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced succession process Neuronetics reiterates g... Full story
Yahoo Finance • 3 months ago
Neuronetics Inc. (NASDAQ:STIM) is one of the best-performing NASDAQ stocks according to analysts. On June 10, Neuronetics announced its significant presence at the 13th Annual Clinical TMS Society/CTMSS Meeting and provided an update on Gr... Full story
Yahoo Finance • 4 months ago
MALVERN. Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever... Full story
Yahoo Finance • 4 months ago
* Neuronetics (NASDAQ:STIM [https://seekingalpha.com/symbol/STIM]) will be added to the Russell 3000 and Russell 2000 Indexes after market close on June 30, 2025. * STIM shares rise 5% post-market on Monday. * Source: Press release [... Full story
Yahoo Finance • 4 months ago
MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients wheneve... Full story
Yahoo Finance • 5 months ago
New national awareness day will foster greater understanding of transcranial magnetic stimulation (TMS) treatment The company will celebrate on social media, sharing patient and provider stories that highlight the impact NeuroStar has as a... Full story
Yahoo Finance • 5 months ago
MALVERN, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transformin... Full story
Yahoo Finance • 6 months ago
MALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients wheneve... Full story
Yahoo Finance • 6 months ago
MALVERN, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) is issuing this press release to update the reporting of its financial results for the fourth quarter and full year ending... Full story
Yahoo Finance • 7 months ago
MALVERN, Pa., March 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transformi... Full story